advertisement
ATC Level5: L01XC04 - Alemtuzumab
ATC Level1:
- L - Antineoplastic and immunomodulating agents
ATC Level2:
- L01 - Antineoplastic agents
ATC Level3:
- L01X - Other antineoplastic agents
ATC Level4:
- L01XC - Monoclonal antibodies
ATC Level5:
Drugs in ATC category "L01XC04":
- Alemtuzumab (Alemtuzumab)
- WARNING: AUTOIMMUNITY, INFUSION REACTIONS, AND MALIGNANCIES LEMTRADA causes serious, sometimes fatal, autoimmune conditions such as immune thrombocytopenia and anti-glomerular basement membrane disease. Monitor complete blood counts with differential, serum creatinine levels, and urinalysis with urine cell counts at periodic intervals for 48 months after the last dose of...
- Campath
- Alemtuzumab is used to treat a certain type of leukemia (B-cell chronic lymphocytic leukemia , also known as B-CLL) in patients who have not responded to other cancer chemotherapy drugs (e.g., fludarabine ). This medication works by stopping the growth of cancer cells.
- Kempas
- MabCampath
advertisement
The information was verified by Dr. Rachana Salvi, MD Pharmacology
© 2002 - 2024 "sdrugs.com". All Rights Reserved